StockViews Preps Paid, On-Demand Research Platform; Readies International Coverage

The platform will allow buy-side firms to request specific custom research notes from freelance analysts.

thomas-beevers-stockviews

The platform, which has until now been free of charge, allows "analysts"─not necessarily industry analysts, but rather any member of the platform who contributes recommendations─to post their stock recommendations or thesis, with a "rating" of buy, sell or neutral. The site then tracks the performance of recommendations in real time to compare them against other analysts. As part of the revamp, StockViews has improved this real-time tracking element, enabling users to provide immediate feedback

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here